Asset
Amantadine Hydrochloride
Supernus Pharmaceuticals Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (0)
No records yet.
FDA applications (2)
| Application | Type | Applicant |
|---|---|---|
| NDA 208944 | NDA | SUPERNUS PHARMACEUTICALS INC |
| NDA 209410 | NDA | SUPERNUS PHARMACEUTICALS INC |
Marketed products (6)
- GOCOVRI
- GOCOVRI
- OSMOLEX ER
- OSMOLEX ER
- OSMOLEX ER
- OSMOLEX ER